FROM THE MEDIA

The National Emerging Infectious Diseases Laboratories (NEIDL)2 at Boston University in the US has conducted research that validates the effectiveness of UV-C light sources on the inactivation of SARS-CoV-2, the virus that causes COVID-19.

Since the start of the SARS CoV-2 pandemic, Dr. Anthony Griffiths, Associate Professor of Microbiology at Boston University School of Medicine and his team have been working on developing tools to support scientific advancement in this field.3 During their research they have treated inoculated material with different doses of UV-C radiation coming from a UV light source and assessed the inactivation capacity under various conditions. The team applied a dose of 5mJ/cm2, resulting in a reduction of the SARS-CoV-2 virus of 99% in 6 seconds. Based on the data, it was determined that a dose of 22mJ/cm2 will result in a reduction of 99.9999% in 25 seconds.

2 The NEIDL is a state-of-the-art research facility that encompasses significant containment laboratories at Biosafety Level -2, -3, and -4

3 Dr. Griffiths’ team develops vaccines and therapeutics for Risk Group 3 and 4 viruses, which include organisms that can cause serious or deadly diseases in humans